Clin2
NCT07775391Possibly a fitRecruiting

Stem cell infusion for early menopause

Premature Ovarian Insufficiency

Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.

This trial tests whether a single infusion of stem cells made from human umbilical cord tissue can help women with premature ovarian insufficiency (early menopause) by improving ovarian function and reducing menopause symptoms. Participants will continue their usual hormone replacement therapy during the study.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
59 people
Ages
18 years to 40 years
Study type
Interventional

Who can take part

  • You are between 18 and 40 years old.
  • You have been diagnosed with premature ovarian insufficiency (early menopause), meaning your periods are very irregular or absent for more than 4 months, and your FSH (follicle-stimulating hormone) level is above 25 U/L on two tests taken at least 4 weeks apart.
  • You have either fewer than 5 antral follicles (small follicles) in both ovaries combined, or your AMH (anti-Müllerian hormone) level is very low (≤7.85 pmol/L).
  • You have been on a stable dose of hormone replacement therapy (HRT) for at least 3 months and are willing to continue it throughout the study.
  • You do not plan to become pregnant and are willing to use effective contraception during the trial.
  • You have a negative pregnancy test and are not breastfeeding.
  • You have not had cancer, and you do not have certain other medical conditions (like thyroid problems, abnormal chromosomes, or severe liver/kidney disease).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06481969Recruiting
Fat cell therapy for premature ovarian failure

This trial uses your own fat cells (called stromal vascular fraction) to try to improve ovarian function and help you become pregnant if you have premature ovarian insufficiency. It may help restore your egg supply and menstrual cycles.

Beijing, Beijing Municipality
NCT07115082Recruiting· Phase 1/Phase 2
Stem cells from amniotic fluid for early menopause

This study tests whether stem cells from the fluid around a baby (amniotic membrane) can help women with premature ovarian insufficiency improve their chances of getting pregnant. It is designed for women under 40 who have not had a period for months and have high FSH levels.

Shanghai
NCT07511660Enrolling by invitation
Ovarian cell injection for perimenopause symptom relief

This trial tests injecting special cells called Muse cells into the ovaries to help relieve perimenopause symptoms and possibly restore ovarian function. It may help women experiencing irregular periods, hot flashes, sleep problems, mood changes, or trouble thinking clearly.

Monterrey, Nuevo León
NCT06754332Not yet recruiting· Phase 1
HCG injection for early menopause-related infertility

This trial tests whether a hormone injection called HCG can activate dormant egg follicles in women under 40 who have gone through premature ovarian insufficiency (POI). If successful, it may help these women conceive.

NCT07020429Not yet recruiting
Herbal medicine for early menopause in women

This study tests a Chinese herbal medicine called Huanjingjian Decoction to see if it helps women with premature ovarian insufficiency (early menopause) have more regular periods and improve hormone levels. If you are under 40 and have this condition, this treatment might help you.

Shanghai
NCT07815509Not yet recruiting· Phase 2
Finerenone for early menopause in women under 40

This trial tests a medicine called finerenone to see if it can help women with premature ovarian insufficiency (early menopause). It may help restore ovarian function and improve quality of life.

Shenzhen, Guangdong

Hear when a new Premature Ovarian Insufficiency trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.